Chengxin Xu1, Jing Wang2, Xiaxia Jin2, Yuan Yuan2, Guoguang Lu2. 1. Department of Clinical Laboratory, Shanghai Jiading District Jiangqiao hospital, 800 Huang Jia Hua Yuan Road, Jiading District, Shanghai. 2. Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province, Taizhou Enze Medical Center (Group), 150 Ximen Road, Linhai, Zhejiang Province, China.
Abstract
BACKGROUND/AIMS: Nucleated red blood cell (NRBC) is an immature red blood cell, which can appear in the peripheral blood of newborns but not in normal adults. However, in the presence of hemorrhage, severe hypoxia, or severe infection, NRBCs may exist in adult blood and are associated with prognosis. The aims of this study were to establish a predictive model for the outcome of patients with severe acute pancreatitis (SAP) based on NRBCs. MATERIALS AND METHODS: Data from 92 patients with SAP were retrospectively collected for the study. We used chi-square automatic interaction detection (CHAID) to explore a prediction model of mortality in patients with SAP by NRBCs. RESULTS: During the 90-day follow-up, 11 participants (12.0%) died. The NRBC-positive rate of nonsurvivors was much higher than survivors (90.9% vs. 23.5%). Charlson Comorbidity Index (CCI), Acute Physiology and Chronic Health Evaluation II (APACHE II), Ranson score, and serum C-reactive protein were higher in nonsurvivors (5.0, 29.0, 6.0, and 140.0 g/L) than survivors (3.0, 13.0, 4.0, and 54.7 g/L). A CHAID model including NRBC, CCI, APACHE II score, and Ranson score showed that NRBCs differentiated well between nonsurvivors and survivors. All patients with SAP survived when they had a negative test result for NRBCs and CCI was below 7. All patients died when they had a positive test result for NRBCs and APACHE II score exceeded 30. Among patients whose NRBC test result was positive and APACHE II score was below 30, if the Ranson score was less than 5, the mortality rate was only 5.6%, whereas the mortality rate was 66.7% if the Ranson score exceeded 5. A validated population of 32 patients showed that the accuracy of the prediction model was 100%. CONCLUSION: NRBC combined with CCI, APACHE II, and Ranson score can predict 90-day mortality of patients with SAP.
BACKGROUND/AIMS: Nucleated red blood cell (NRBC) is an immature red blood cell, which can appear in the peripheral blood of newborns but not in normal adults. However, in the presence of hemorrhage, severe hypoxia, or severe infection, NRBCs may exist in adult blood and are associated with prognosis. The aims of this study were to establish a predictive model for the outcome of patients with severe acute pancreatitis (SAP) based on NRBCs. MATERIALS AND METHODS: Data from 92 patients with SAP were retrospectively collected for the study. We used chi-square automatic interaction detection (CHAID) to explore a prediction model of mortality in patients with SAP by NRBCs. RESULTS: During the 90-day follow-up, 11 participants (12.0%) died. The NRBC-positive rate of nonsurvivors was much higher than survivors (90.9% vs. 23.5%). Charlson Comorbidity Index (CCI), Acute Physiology and Chronic Health Evaluation II (APACHE II), Ranson score, and serum C-reactive protein were higher in nonsurvivors (5.0, 29.0, 6.0, and 140.0 g/L) than survivors (3.0, 13.0, 4.0, and 54.7 g/L). A CHAID model including NRBC, CCI, APACHE II score, and Ranson score showed that NRBCs differentiated well between nonsurvivors and survivors. All patients with SAP survived when they had a negative test result for NRBCs and CCI was below 7. All patientsdied when they had a positive test result for NRBCs and APACHE II score exceeded 30. Among patients whose NRBC test result was positive and APACHE II score was below 30, if the Ranson score was less than 5, the mortality rate was only 5.6%, whereas the mortality rate was 66.7% if the Ranson score exceeded 5. A validated population of 32 patients showed that the accuracy of the prediction model was 100%. CONCLUSION: NRBC combined with CCI, APACHE II, and Ranson score can predict 90-day mortality of patients with SAP.
Authors: Axel Stachon; Tim Holland-Letz; Reiner Kempf; Andreas Becker; Jochen Friese; Michael Krieg Journal: Clin Chem Lab Med Date: 2006 Impact factor: 3.694
Authors: L Passantino; M Altamura; A Cianciotta; R Patruno; A Tafaro; E Jirillo; G F Passantino Journal: Immunopharmacol Immunotoxicol Date: 2002-11 Impact factor: 2.730
Authors: Davinia Morera; Nerea Roher; Laia Ribas; Joan Carles Balasch; Carmen Doñate; Agnes Callol; Sebastian Boltaña; Steven Roberts; Giles Goetz; Frederick W Goetz; Simon A MacKenzie Journal: PLoS One Date: 2011-10-27 Impact factor: 3.240
Authors: José Gildo de Moura Monteiro Júnior; Dilênia de Oliveira Cipriano Torres; Maria Cleide Freire Clementino da Silva; Tadzia Maria de Brito Ramos; Marilene Leite Alves; Wellington Jorge Nunes Filho; Edgar Paulo Damasceno; Antônio Fernandes Brunet; Márcio Sommer Bittencourt; Rodrigo Pinto Pedrosa; Dário Celestino Sobral Filho Journal: PLoS One Date: 2015-12-29 Impact factor: 3.240
Authors: José Gildo de Moura Monteiro Júnior; Dilênia de Oliveira Cipriano Torres; Maria Cleide Freire Clementino da Silva; Cyntia Maria de Holanda Martins; Izadora Karina da Silva; Monique Evelyn Mendonça do Nascimento; Ana Célia Oliveira Dos Santos; Ulisses Ramos Montarroyos; Dário Celestino Sobral Filho Journal: PLoS One Date: 2018-04-18 Impact factor: 3.240